In a report released today, Joseph France from Cantor Fitzgerald maintained a Buy rating on The Ensign Group (NASDAQ: ENSG), with a price target of $42. The company’s shares opened today at $37.04.
France commented:
“We rate ENSG Overweight. We believe one of ENSG’s great strengths is acquiring and turning around underperforming skilled nursing and senior housing assets and mitigating risk by, for the most part, avoiding the high end of the market. We continue to find skilled nursing attractive because of its potential to capitalize on bundled payments and shared savings programs. $42 price target is derived from a blend of our DCF and comparable-companies analysis.”
According to TipRanks.com, France is a 5-star analyst with an average return of 10.1% and a 59.7% success rate. France covers the Services sector, focusing on stocks such as Cross Country Healthcare, Five Star Quality Care, and Addus Homecare Corp.
Currently, the analyst consensus on The Ensign Group is a Strong Buy with an average price target of $39.67.
See today’s analyst top recommended stocks >>
The Ensign Group’s market cap is currently $1.95B and has a P/E ratio of 28.37. The company has a Price to Book ratio of 3.61.
Based on the recent corporate insider activity of 66 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
The Ensign Group, Inc. engages in the provision of healthcare services, as well as urgent care centers and mobile ancillary businesses. It operates through the following segments: Transitional and Skilled Services, Assisted and Independent Living Services, and Home Health and Hospice Services.
